Biontech Se ADR (BNTX)

$102.70 +2.99 (3.00%)
Market Cap 22.45B
Revenue (ttm) 2.98B
Net Income (ttm) -719.92M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -24.18%
Debt to Equity Ratio 0.01
Volume 1,046,200
Avg Vol 816,572
Day's Range N/A - N/A
Shares Out 225.18M
Stochastic %K 13%
Beta 1.54
Analysts Strong Sell
Price Target $136.84

Company Profile

BioNTech SE, a biotechnology company, develops and commercializes immunotherapies to treat cancer and infectious diseases in Germany. The company develops BNT111, which is in Phase 2 clinical trial for advance melanoma; BNT113, which is in Phase 2 clinical trial to treat head and neck squamous cell carcinoma; BNT116, which is in Phase I clinical trial for non-small cell lung cancer; BNT142, which is in phase 1/2 clinical trial for multiple solid tumors; BNT151, which is in phase 1/2 clinical tri...

Industry: Biotechnology
Sector: Healthcare
Phone: 49 6131 9084
Fax: 49 6131 9084
Address:
An der Goldgrube 12, Mainz, Germany
SuperGreenToday
SuperGreenToday Nov. 27 at 12:19 AM
$BNTX Share Price: $102.76 Contract Selected: Jun 18, 2026 $105 Calls Buy Zone: $9.69 – $11.97 Target Zone: $16.48 – $20.14 Potential Upside: 61% ROI Time to Expiration: 203 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
taxplanr
taxplanr Nov. 26 at 7:53 PM
Not so fast on that malignantRNA flu vaccine $BNTX $PFE $MRNA https://childrenshealthdefense.org/defender/pfizer-claims-victory-mrna-flu-shot-critics-flaws-safety-signals/?utm_source=cc&utm_medium=email&utm_campaign=defender&utm_id=20251125
0 · Reply
taxplanr
taxplanr Nov. 26 at 3:45 PM
The pulsed electromagnetic frequencies from Truvaga Plus $ECOR Disassemble the lipid nanoparticles microbots and blood clots from the C19 bioweapons Really scary video of the bioweapon in action $BNTX $MRNA $PFE https://anamihalceamdphd.substack.com/p/self-assembly-of-a-mesogen-microchip?utm_source=post-email-title&publication_id=956088&post_id=179953690&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
0 · Reply
taxplanr
taxplanr Nov. 26 at 3:39 PM
$BNTX Dec 4 approaches ... get your hedges in $CVAC while triple digits last https://finviz.com/news/239392/biontech-shares-progress-on-exchange-offer-for-curevac-shares-and-highlights-december-3-2025-at-9-00-am-eastern-time-expiration
0 · Reply
BullYa
BullYa Nov. 26 at 2:33 PM
$BNTX $95 ?
1 · Reply
taxplanr
taxplanr Nov. 26 at 4:10 AM
malignantRNA C19 bioweapons deemed chemical lobotomies by McCullough Foundation $BNTX $MRNA $PFE https://www.instagram.com/reel/DRfNugpjbjI/?igsh=MWdpMGQ0eXlxbW9vZg==
1 · Reply
HedgeAlerts
HedgeAlerts Nov. 26 at 2:42 AM
Hedge Alert Live - Protect Your Portfolio Contract: $BNTX $97.50 Put · DEC 19, 2025 Exp Entry Price: $2.85 - $2.90 Exit Price Target: $6.38 Profit Margin: +120% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 26 at 1:39 AM
💎 LiquidTheta® Live Actionable Trade Asset: $BNTX Contracts: $BNTX January 15, 2027 $98 Calls Scale in: $20.27- $24.77 Scale out: $78.82-$135.12 Profit Potential : 112% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
taxplanr
taxplanr Nov. 25 at 8:02 PM
Remember the PPP $BNTX $MRNA $PFE karma is a b*tch https://x.com/akafaceUS/status/1992795722899693636?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1992795722899693636%7Ctwgr%5E9c43f82f2b530bc3f34f3bbebd1501b08592e7df%7Ctwcon%5Es1_c10&ref_url=https%3A%2F%2Frevolver.news%2F2025%2F11%2Fabc-reporter-gets-10-years-in-prison-for-being-a-63-million-fraud%2F
0 · Reply
taxplanr
taxplanr Nov. 25 at 7:38 PM
$BNTX $MRNA $PFE bioweapons bring fewer live births in 2023 Not that his proves any depopulation conspiracy https://jarle.substack.com/p/covid-19-vaccination-was-linked-to?utm_source=cross-post&publication_id=1412630&post_id=179921690&utm_campaign=548354&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
0 · Reply
Latest News on BNTX
BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration

Nov 26, 2025, 7:30 AM EST - 1 day ago

BioNTech Shares Progress on Exchange Offer for CureVac Shares and Highlights December 3, 2025, at 9:00 a.m. Eastern Time Expiration

BioNTech SE (BNTX) Discusses Oncology Innovation Strategy, Combination Therapies and Personalized Cancer Immunotherapies Transcript

Nov 17, 2025, 6:17 PM EST - 9 days ago

BioNTech SE (BNTX) Discusses Oncology Innovation Strategy, Combination Therapies and Personalized Cancer Immunotherapies Transcript

Pfizer sheds BioNTech stake years after blockbuster COVID vaccine tie-up

Nov 13, 2025, 5:20 PM EST - 13 days ago

Pfizer sheds BioNTech stake years after blockbuster COVID vaccine tie-up

PFE

Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run

Nov 13, 2025, 11:10 AM EST - 14 days ago

Pfizer Seeks To Exit BioNTech Investment After Lucrative Covid Vaccine Run

PFE

BioNTech says collaboration with Pfizer remains unchanged

Nov 13, 2025, 8:17 AM EST - 14 days ago

BioNTech says collaboration with Pfizer remains unchanged

PFE

BioNTech Q3 Earnings: Plenty Of Cash And Pipeline Potential, But Still A Hold

Nov 3, 2025, 1:44 PM EST - 24 days ago

BioNTech Q3 Earnings: Plenty Of Cash And Pipeline Potential, But Still A Hold

BioNTech SE (BNTX) Q3 2025 Earnings Call Transcript

Nov 3, 2025, 12:46 PM EST - 24 days ago

BioNTech SE (BNTX) Q3 2025 Earnings Call Transcript

BioNTech Sees Higher 2025 Sales Driven By Bristol Myers Partnership

Nov 3, 2025, 10:29 AM EST - 24 days ago

BioNTech Sees Higher 2025 Sales Driven By Bristol Myers Partnership

BMY

BioNTech lifts 2025 revenue guidance on BMS partnership payment

Nov 3, 2025, 6:47 AM EST - 24 days ago

BioNTech lifts 2025 revenue guidance on BMS partnership payment

BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update

Nov 3, 2025, 6:45 AM EST - 24 days ago

BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update

BioNTech to Host Innovation Series R&D Day on November 11, 2025

Oct 28, 2025, 7:45 AM EDT - 4 weeks ago

BioNTech to Host Innovation Series R&D Day on November 11, 2025

BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025

Oct 27, 2025, 7:45 AM EDT - 4 weeks ago

BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025

BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.

Oct 22, 2025, 6:45 AM EDT - 5 weeks ago

BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.

Moderna Vs BioNTech: Who's Winning The Post-COVID Race

Oct 18, 2025, 9:30 AM EDT - 5 weeks ago

Moderna Vs BioNTech: Who's Winning The Post-COVID Race

MRNA

Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead

Oct 8, 2025, 10:15 AM EDT - 7 weeks ago

Healthcare Stocks Are Rising: Here Are 2 With Even More Upside Ahead

CRSP

BioNTech SE, InstaDeep Ltd - Special Call

Oct 1, 2025, 6:52 PM EDT - 2 months ago

BioNTech SE, InstaDeep Ltd - Special Call

Why BioNTech Stock Jumped by Nearly 4% on Wednesday

Oct 1, 2025, 6:13 PM EDT - 2 months ago

Why BioNTech Stock Jumped by Nearly 4% on Wednesday

BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025

Sep 23, 2025, 6:45 AM EDT - 2 months ago

BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025

Why BioNTech Stock Bumped Higher Today

Sep 22, 2025, 6:45 PM EDT - 2 months ago

Why BioNTech Stock Bumped Higher Today

Mizuho's Jared Holz: There's not much value left in vaccine stocks

Sep 19, 2025, 11:40 AM EDT - 2 months ago

Mizuho's Jared Holz: There's not much value left in vaccine stocks

MRNA NVAX PFE

Why BioNTech Stock Sank by More Than 7% Today

Sep 12, 2025, 6:19 PM EDT - 2 months ago

Why BioNTech Stock Sank by More Than 7% Today

COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says

Sep 12, 2025, 1:37 PM EDT - 2 months ago

COVID vaccine makers' shares fall as Trump officials to link shots to child deaths, report says

JNJ KVUE MRNA PFE

BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy

Sep 8, 2025, 2:01 PM EDT - 2 months ago

BioNTech, Bristol Myers Squibb Show Tumor Shrinkage In Lung Cancer Immunotherapy

BMY

BioNTech, Bristol Myers' immunotherapy shows encouraging tumour shrinkage in Phase II trial

Sep 8, 2025, 11:05 AM EDT - 2 months ago

BioNTech, Bristol Myers' immunotherapy shows encouraging tumour shrinkage in Phase II trial

BMY

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

Sep 8, 2025, 11:00 AM EDT - 2 months ago

First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity

Pfizer, partner BioNTech say updated COVID shot shows better immune response

Sep 8, 2025, 7:02 AM EDT - 2 months ago

Pfizer, partner BioNTech say updated COVID shot shows better immune response

PFE

Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula

Sep 8, 2025, 6:45 AM EDT - 2 months ago

Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula

PFE

Why BioNTech Stock Crushed the Market Today

Sep 5, 2025, 4:41 PM EDT - 2 months ago

Why BioNTech Stock Crushed the Market Today

BioNTech, Duality score initial trial win with breast cancer precision drug

Sep 5, 2025, 5:13 AM EDT - 2 months ago

BioNTech, Duality score initial trial win with breast cancer precision drug

mRNA Biotechs - Long-Term Value Risks Abound

Aug 28, 2025, 6:20 AM EDT - 3 months ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY DHR GRAL ILMN IONS MRNA RGEN

Pfizer and BioNTech's COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

Aug 27, 2025, 12:50 PM EDT - 3 months ago

Pfizer and BioNTech's COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19

PFE

CureVac settles patent dispute litigation with Pfizer and BioNTech

Aug 7, 2025, 9:00 PM EDT - 3 months ago

CureVac settles patent dispute litigation with Pfizer and BioNTech

CVAC PFE

These Analysts Revise Their Forecasts On BioNTech After Q2 Results

Aug 5, 2025, 1:36 PM EDT - 4 months ago

These Analysts Revise Their Forecasts On BioNTech After Q2 Results

BioNTech SE (BNTX) Q2 2025 Earnings Call Transcript

Aug 4, 2025, 1:56 PM EDT - 4 months ago

BioNTech SE (BNTX) Q2 2025 Earnings Call Transcript

BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth

Aug 4, 2025, 10:32 AM EDT - 4 months ago

BioNTech Narrows Losses, Q2 Revenue Doubles As Vaccine Collaboration Drives Growth

BioNTech Stock Rises as Drug Maker Beats Earnings Expectations.

Aug 4, 2025, 7:01 AM EDT - 4 months ago

BioNTech Stock Rises as Drug Maker Beats Earnings Expectations.

BioNTech's Q2 revenues double on higher COVID vaccine sales

Aug 4, 2025, 6:52 AM EDT - 4 months ago

BioNTech's Q2 revenues double on higher COVID vaccine sales

BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update

Aug 4, 2025, 6:45 AM EDT - 4 months ago

BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update

Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent

Aug 1, 2025, 4:51 PM EDT - 4 months ago

Pfizer and BioNTech lose appeal in London over Moderna COVID vaccine patent

MRNA PFE

Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

Aug 1, 2025, 8:31 AM EDT - 4 months ago

Pres. Trump's push to lower drug prices 'is a good starting point', says Dr. Scott Gottlieb

ABBV ABT ALNY AMGN ARGX AZN BAX

President Trump demands drugmakers slash prices within 60 days

Aug 1, 2025, 6:54 AM EDT - 4 months ago

President Trump demands drugmakers slash prices within 60 days

ABBV ABT ALNY AMGN ARGX AZN BAX

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

Aug 1, 2025, 5:59 AM EDT - 4 months ago

Pfizer, BioNTech lose UK appeal to overturn Moderna's COVID vaccine patent win

MRNA PFE

Pandemic darlings Moderna, BioNTech are now on two different paths

Jul 31, 2025, 7:00 AM EDT - 4 months ago

Pandemic darlings Moderna, BioNTech are now on two different paths

MRNA

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

Jul 25, 2025, 2:30 AM EDT - 4 months ago

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-Adapted COVID-19 Vaccine in the European Union

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European Union

Jul 25, 2025, 2:30 AM EDT - 4 months ago

Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European Union

PFE

8MM Exanthema Market Report 2025-2034 | Rising Viral Infections and Diagnostic Innovations Across Major Markets Fueling Growth

Jul 23, 2025, 4:11 AM EDT - 4 months ago

8MM Exanthema Market Report 2025-2034 | Rising Viral Infections and Diagnostic Innovations Across Major Markets Fueling Growth

PFE

BioNTech to Report Second Quarter 2025 Financial Results and Corporate Update on August 4, 2025

Jul 21, 2025, 6:45 AM EDT - 4 months ago

BioNTech to Report Second Quarter 2025 Financial Results and Corporate Update on August 4, 2025

BioNTech Announces Ryan Richardson to Step Down from the Management Board

Jul 17, 2025, 8:30 AM EDT - 4 months ago

BioNTech Announces Ryan Richardson to Step Down from the Management Board

Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win

Jul 10, 2025, 7:18 AM EDT - 5 months ago

Pfizer, BioNTech ask UK court to overturn Moderna's COVID vaccine patent win

MRNA PFE

5 Stocks To Ride The German Market Rally

Jun 16, 2025, 3:06 PM EDT - 5 months ago

5 Stocks To Ride The German Market Rally

FMS SAP

SuperGreenToday
SuperGreenToday Nov. 27 at 12:19 AM
$BNTX Share Price: $102.76 Contract Selected: Jun 18, 2026 $105 Calls Buy Zone: $9.69 – $11.97 Target Zone: $16.48 – $20.14 Potential Upside: 61% ROI Time to Expiration: 203 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
taxplanr
taxplanr Nov. 26 at 7:53 PM
Not so fast on that malignantRNA flu vaccine $BNTX $PFE $MRNA https://childrenshealthdefense.org/defender/pfizer-claims-victory-mrna-flu-shot-critics-flaws-safety-signals/?utm_source=cc&utm_medium=email&utm_campaign=defender&utm_id=20251125
0 · Reply
taxplanr
taxplanr Nov. 26 at 3:45 PM
The pulsed electromagnetic frequencies from Truvaga Plus $ECOR Disassemble the lipid nanoparticles microbots and blood clots from the C19 bioweapons Really scary video of the bioweapon in action $BNTX $MRNA $PFE https://anamihalceamdphd.substack.com/p/self-assembly-of-a-mesogen-microchip?utm_source=post-email-title&publication_id=956088&post_id=179953690&utm_campaign=email-post-title&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
0 · Reply
taxplanr
taxplanr Nov. 26 at 3:39 PM
$BNTX Dec 4 approaches ... get your hedges in $CVAC while triple digits last https://finviz.com/news/239392/biontech-shares-progress-on-exchange-offer-for-curevac-shares-and-highlights-december-3-2025-at-9-00-am-eastern-time-expiration
0 · Reply
BullYa
BullYa Nov. 26 at 2:33 PM
$BNTX $95 ?
1 · Reply
taxplanr
taxplanr Nov. 26 at 4:10 AM
malignantRNA C19 bioweapons deemed chemical lobotomies by McCullough Foundation $BNTX $MRNA $PFE https://www.instagram.com/reel/DRfNugpjbjI/?igsh=MWdpMGQ0eXlxbW9vZg==
1 · Reply
HedgeAlerts
HedgeAlerts Nov. 26 at 2:42 AM
Hedge Alert Live - Protect Your Portfolio Contract: $BNTX $97.50 Put · DEC 19, 2025 Exp Entry Price: $2.85 - $2.90 Exit Price Target: $6.38 Profit Margin: +120% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 26 at 1:39 AM
💎 LiquidTheta® Live Actionable Trade Asset: $BNTX Contracts: $BNTX January 15, 2027 $98 Calls Scale in: $20.27- $24.77 Scale out: $78.82-$135.12 Profit Potential : 112% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
taxplanr
taxplanr Nov. 25 at 8:02 PM
Remember the PPP $BNTX $MRNA $PFE karma is a b*tch https://x.com/akafaceUS/status/1992795722899693636?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1992795722899693636%7Ctwgr%5E9c43f82f2b530bc3f34f3bbebd1501b08592e7df%7Ctwcon%5Es1_c10&ref_url=https%3A%2F%2Frevolver.news%2F2025%2F11%2Fabc-reporter-gets-10-years-in-prison-for-being-a-63-million-fraud%2F
0 · Reply
taxplanr
taxplanr Nov. 25 at 7:38 PM
$BNTX $MRNA $PFE bioweapons bring fewer live births in 2023 Not that his proves any depopulation conspiracy https://jarle.substack.com/p/covid-19-vaccination-was-linked-to?utm_source=cross-post&publication_id=1412630&post_id=179921690&utm_campaign=548354&isFreemail=true&r=18m8lm&triedRedirect=true&utm_medium=email
0 · Reply
taxplanr
taxplanr Nov. 25 at 7:33 PM
Last chance for $CVAC shareholders to dump $BNTX
0 · Reply
taxplanr
taxplanr Nov. 25 at 3:26 PM
Micro clotting children $BNTX $MRNA $PFE https://www.instagram.com/reel/DRdVmL6grWV/?igsh=YXphZnNzczJlNmFn
0 · Reply
taxplanr
taxplanr Nov. 25 at 3:17 PM
$BNTX insider dumping imminent
0 · Reply
taxplanr
taxplanr Nov. 25 at 3:05 PM
$ECOR $BNTX $PFE
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 25 at 2:42 AM
Hedge Alert Live - Protect Your Portfolio Contract: $BNTX $95.00 Put · DEC 19, 2025 Exp Entry Price: $2.95 - $3.40 Exit Price Target: $6.67 Profit Margin: +126% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply
Ben_Dover_U
Ben_Dover_U Nov. 24 at 8:46 PM
$BNTX $MRNA $PFE YEAH She did!! multiple boosters jabs as well... Remember, her side of the family is heavily invested in big Pharma, and is on the payroll as well. They do nothing But trash RFK Jr. but, he's not the one suffering from immune system destruction via the MRNA gene therapies.
0 · Reply
taxplanr
taxplanr Nov. 24 at 5:40 PM
$BNTX $MRNA $PFE
2 · Reply
taxplanr
taxplanr Nov. 24 at 5:40 PM
$BNTX $MRNA $PFE C19 bioweapons linked to MS Lupus Diabetes Rheumatoid Arthritis Graves' Disease and Hashinoto's Thyroiditis https://www.thefocalpoints.com/p/breaking-study-covid-19-vaccines-f6c?r=14jb45&utm_campaign=post&utm_medium=web&showWelcomeOnShare=false
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Nov. 24 at 1:15 PM
$BNTX RSI: 34.64, MACD: -1.2948 Vol: 3.40, MA20: 103.66, MA50: 102.76 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
Snickers0077
Snickers0077 Nov. 24 at 1:02 PM
$BNTX
0 · Reply
LiquidThetaOptions
LiquidThetaOptions Nov. 24 at 8:09 AM
💎 LiquidTheta® Live Actionable Trade Asset: $BNTX Contracts: $BNTX January 15, 2027 $98 Calls Scale in: $19.82- $24.22 Scale out: $77.07-$132.12 Profit Potential : 365% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
HedgeAlerts
HedgeAlerts Nov. 23 at 4:04 AM
Hedge Alert Live - Protect Your Portfolio Contract: $BNTX $95.00 Put · DEC 19, 2025 Exp Entry Price: $3.45 - $4.50 Exit Price Target: $6.93 Profit Margin: +101% Hold Period: 1-3 days MAX ONLY USE THESE ALERTS ON RED/DOWN MARKET DAYS. Monetize Red Market Days: https://hedgealerts.com
0 · Reply